Vir Biotechnology Inc
Change company Symbol lookup
Select an option...
VIR Vir Biotechnology Inc
$NQUSB40401010N Nasdaq US Benchmark Diversified Reta
IVZ Invesco Ltd
SPLK Splunk Inc
TW Tradeweb Markets Inc
CMPGY Compass Group PLC
DZSI DZS Inc
FCPT Four Corners Property Trust Inc
UGI UGI Corp
BMI Badger Meter Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus (HBV), influenza A virus, and human immunodeficiency virus (HIV). Its product candidates include Sotrovimab and VIR-7832, VIR-2218, VIR-3434, VIR-2482, VIR-1111. It is engaged in developing differentiated monoclonal antibodies (mAbs) as well as vaccines and small molecules that focuses is on treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-2218 and VIR-3434, are for the treatment of HBV. VIR-2482 is an investigational IM administered influenza A-neutralizing mAb.

Postmarket

Last Trade
Delayed
$29.97
-0.17 (-0.56%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$30.14
Day's Change
0.23 (0.77%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
30.95
Day's Low
29.35
Volume
(Average)
Volume:
859,517

10-day average volume:
895,288
859,517

Take-Two stock sinks as analysts walk off mobile weakness, focus on pipeline

2:06 pm ET November 8, 2022 (MarketWatch)
Print

By Wallace Witkowski

Stock price drops as much as 17% following $400 million cut to sales forecast

Take-Two Interactive Software Inc. shares fell double-digits Tuesday after Wall Street absorbed a hefty outlook cut owing to the videogame publisher's overestimate of the mobile market in the latter half of the year.

Take-Two (TTWO) shares dropped as much as 17% Monday, and were last down 14%, compared with 1% gains on both the S&P 500 index and tech-heavy Nasdaq Composite Index .

Known for its "Grand Theft Auto" and "NBA 2K" titles, Take-Two reported late Monday weakness in its mobile segment, mostly acquired from its acquisition of Zynga, which closed in May, and unidentified pipeline "shifts" that, on the call with analysts, Chief Executive Strauss Zelnick had characterized as "modest."

Execs also admitted earlier forecasts had relied too heavily on mobile performing better in the second half of the year.

Read: Videogame sales heading for decline in U.S., but one analyst sees a 2023 rebound

Cowen analyst Doug Creutz said he was puzzled as to the reduced outlook, which he called "frustrating," not so much as to the outcome as to management's thought process. Take-Two "meaningfully" lowered its outlook, Creutz said, which he said had been uncharacteristically aggressive."

"It's not clear to us why management would have assumed a significant improvement in performance (to a quarterly run-rate close to $700MM, it appears) for an asset that they had just acquired," Creutz said. "We are inclined not to overreact given management's historically reliable approach to guidance, though we remain puzzled at the thought process that led to the overly aspirational expectations."

Morgan Stanley analyst Matthew Cost, with an overweight rating, said he sees thepipeline and longer-term opportunity as still intact.

"We believe Zynga will likely remain an overhang until investors become confident that mobile gaming has bottomed," Cost said.

Jefferies analyst Andrew Uerkwitz, with a buy rating, compared waiting for Take-Two stock to turn around to "the tedious nature of side missions" in videogames.

"While it has been frustrating and management erodes investor trust with consecutive guide downs, we believe the risk/reward at these levels is compelling, and it's a matter of when, not if, on the pipeline unlock," Uerkwitz said.

Back in September, Take-Two had a scare when a hacker claimed to have source code and assets of "Grand Theft Auto VI," and published them online. On the call, execs said they have found no evidence that any material data was taken.

Elsewhere in videogames, EU officials digging deeper into Microsoft Corp.'s (MSFT) acquisition of Activision Blizzard Inc. (ATVI), prompting Activision Chief Executive Bobby Kotick to dash off a statement, reminding investors that he had said from the outset "this is a long process."

"This week the European Commission games industry announced that we have entered the second phase of our review in the region," Kotick said. "We will continue to cooperate with the European Commission where, in the countries they represent, we have many employees."

Of the 27 analysts that cover Take-Two, 22 have buy-grade ratings and five have hold ratings. Of those, 17 cut price targets resulting in an average of $141.50, down from a previous $163.42, according to FactSet data.

-Wallace Witkowski

	

(END) Dow Jones Newswires

November 08, 2022 14:06 ET (19:06 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.